Effect of DBS on Quality of Life in Dyskinetic Cerebral Palsy

NCT02097693 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2025-03-30

No results posted yet for this study

Summary

There are limited therapeutical options for patients with secondary dystonia due to cerebral palsy. Pharmacotherapy is often without effect, or side effects are severe. Meanwhile deep brain stimulation (DBS) has proven to be a safe and effective therapy for patients with parkinson´s disease or primary / idiopathic dystonia. Experiences with DBS in patients with dyskinetic cerebral palsy are limited with heterogeneous data.

With STIM-CP we investigate the effect of DBS on quality of life in young patients with a dyskinetic movement disorder (dyskinetic cerebral palsy) due to perinatal hypoxic brain injury. Additionally, the effect of DBS on motor development, speech, memory, attention, cognition and pain perception will be assessed.

Conditions

  • Dyskinetic Cerebral Palsy Due to Perinatal Hypoxia

Sponsors & Collaborators

  • University Hopsital Schleswig Holstein Campus Lübeck

    collaborator OTHER
  • Boston Scientific Corporation

    collaborator INDUSTRY
  • University Hsopital of Magdeburg

    collaborator UNKNOWN
  • University Hospital of Munich

    collaborator UNKNOWN
  • Schoen Klinik Vogtareuth

    collaborator UNKNOWN
  • University Hospital of Tübingen

    collaborator UNKNOWN
  • Heinrich-Heine University, Duesseldorf

    collaborator OTHER
  • Hannover Medical School

    collaborator OTHER
  • University Hospital of Kiel

    collaborator UNKNOWN
  • University Hospital of Würzburg

    collaborator UNKNOWN
  • University Hospital of Freiburg

    collaborator UNKNOWN
  • University Hospital Berlin Charite

    collaborator UNKNOWN
  • University Hospital of Cologne

    lead OTHER

Principal Investigators

  • Anne Koy, MD · University Hospital Cologne, Germany

Eligibility

Min Age
7 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-04
Primary Completion
2020-03-10
Completion
2021-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02097693 on ClinicalTrials.gov